1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
AngioSoma, Inc.

AngioSoma, Inc.

SOAN
AngioSoma, Inc.US flagOther OTC
0.07
USD
+0.01
- -
AngioSoma, Inc.
SOAN
(Other OTC)

Recent

price

0.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Medigen Vaccine Biologics Corp. (6547.TWO)
Adial Pharmaceuticals, Inc. WT EXP 073123 (ADILW)
Decibel Therapeutics, Inc. (DBTX)
Ocuphire Pharma, Inc. (OCUP)
Asarina Pharma AB (publ) (ASAP.ST)
Newron Pharmaceuticals S.p.A. (0QOI.L)
Business
GlobeStar Therapeutics Corporation, formerly known as AngioSoma, Inc., operates as a clinical-stage pharmaceutical enterprise based in New York, New York. Founded in 2016, the company is dedicated to advancing patented drug formulations for treating neurodegenerative conditions, notably multiple sclerosis. Additionally, it delivers a selection of premium wellness and dietary supplements to the market.

Company News

APIChatGPT

  • defenseworld.net

    Head-To-Head Review: AngioSoma (OTCMKTS:SOAN) & Calliditas Therapeutics AB (publ) (NASDAQ:CALT)